This approach has initially been promoted by the joint recommendations for a novel treatment algorithm for T2D by the American (ADA) and European Diabetes Associations (EASD) in 2018 that is continuously being updated (16, 17)
Prioritize protein and fiber even when your appetite is reduced
Difference in gastrointestinal risk associated with use of GLP-1 receptor agonists: A real-world pharmacovigilance study
This timing works well for people with traditional work schedules who cannot afford unpredictable bathroom needs during business hours
Glucagon-like peptide-1 receptor agonists (GLP-1) drugs are a class of medications used to manage type 2 diabetes and treat obesity
[DOI] [PMC free article] [PubMed] [Google Scholar] 58.Gu Y., Sun L., He Y., Yang L., Deng C., Zhou R., Kong T., Zhang W., Chen Y., Li J., et al